On February 3, the final workshop of the European Smart4Fabry project will be held. Smart4Fabry is an initiative whose objective is to obtain a new GLA nanoformulation to address Fabry disease, achieving relevant improvements on the efficacy and tolerance of the treatments based on enzyme replacement therapies. Our technology transfer director Alba Córdoba will lead the session dealing with Production Optimization and Scale-up of the nanoformulation and our CEO Santi Sala will contribute to the final round table.
Online venue:
Further relevant information regarding the event will be provided on https://smart4fabry.eu/
La mejor actitud que podemos adoptar es la de trat...
El equipo de investigadores observó cambios en el...
El gen AtCDF3 promueve una mayor producción de az...
En nuestro post hablamos sobre este interesante tipo de célula del si...
Un nuevo estudio relaciona las temperaturas elevadas en la primera inf...
